Human smoking appears to be influenced in part by genetic factors. Genotype may influence who does or does not smoke and may influence the course and severity of withdrawal responses observed when smoking is terminated. Similarly, genetic factors are important in the regulation of the responses of mice to either acute or chronic nicotine exposure. as well as in the expression of brain receptors which may regulate the responses to nicotine. The studies outlined in this proposal will examine the role of genotype in the regulation of nicotine effects on acute sensitivity, tolerance development and withdrawal. Simultaneously the genetic regulation of putative nicotinic receptor levels, the changes in these levels during treatment and after withdrawal will be investigated. Six inbred strains that differ in response to nicotine and expression of putative nicotinic receptors will be used as parental stocks for both diallel crosses land classical genetic crosses. The parental strains and their crosses will be used to study the influence of genetic factors on: 1) regulation of the acute responses to nicotine and regulation of the expression of nicotinic binding sites, their subtypes and function with the goal of determining the relationship between acute responsiveness and receptors; 2) regulation of tolerance development and changes in the expression of nicotinic receptor number and function with chronic nicotine treatment with the goal of understanding the biochemical basis for the development of itolerance to nicotine; 3) expression of a withdrawal syndrome and the relationship between the extent of tolerance development, the magnitude of receptor changes, and !the severity of the withdrawal; and 4) control of tolerance development after the exposure to nicotinic agents other than nicotine itself. The results obtained in this study should be valuable in establishing an animal model for nicotine tolerance and dependence with an emphasis on the role of genotype in regulating the physiological and biochemical factors that control nicotine responsiveness.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003194-11
Application #
3207781
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1983-09-30
Project End
1994-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
11
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Colorado at Boulder
Department
Type
Other Domestic Higher Education
DUNS #
City
Boulder
State
CO
Country
United States
Zip Code
80309
Semenova, Svetlana; Jin, Xinchun; McClure-Begley, Tristan D et al. (2018) Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of ?4?2* nAChRs in Wistar male rats. Pharmacol Biochem Behav 171:54-65
Moretti, Milena; Fasoli, Francesca; Gotti, Cecilia et al. (2018) Reduced ?4 subunit expression in ?4+- and ?4+- /?2+- nicotinic acetylcholine receptors alters ?4?2 subtype up-regulation following chronic nicotine treatment. Br J Pharmacol 175:1944-1956
Locker, Alicia R; Marks, Michael J; Kamens, Helen M et al. (2016) Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice. Brain Res Bull 123:13-22
McClure-Begley, Tristan D; Esterlis, Irina; Stone, Kathryn L et al. (2016) Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex. eNeuro 3:
Pistillo, Francesco; Fasoli, Francesca; Moretti, Milena et al. (2016) Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner. Pharmacol Res 103:167-76
Fasoli, F; Moretti, M; Zoli, M et al. (2016) In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of ?4?2 nicotinic receptors in cortex and thalamus. Neuropharmacology 108:324-31
Meyers, Erin E; Loetz, Esteban C; Marks, Michael J (2015) Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment. Pharmacol Biochem Behav 130:1-8
Carroll, F Ivy; Navarro, Hernán A; Mascarella, S Wayne et al. (2015) In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at ?6?2 containing neuronal nicotinic acetylcholine receptors. ACS Chem Neurosci 6:920-6
Marks, Michael J; O'Neill, Heidi C; Wynalda-Camozzi, Kelly M et al. (2015) Chronic treatment with varenicline changes expression of four nAChR binding sites in mice. Neuropharmacology 99:142-55
Sanjakdar, Sarah S; Maldoon, Pretal P; Marks, Michael J et al. (2015) Differential roles of ?6?2* and ?4?2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice. Neuropsychopharmacology 40:350-60

Showing the most recent 10 out of 140 publications